Susquehanna International Group
ACET icon

Susquehanna International Group’s Adicet Bio ACET Stock Holding History

Susquehanna International Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,523
Closed -$32.7K – 12190
2025
Q3 		$32.7K Buy
+2,523
New +$29.7K ﹤0.01% 11962
2025
Q2 		– Sell
-28,608
Closed -$346K – 12549
2025
Q1 		$346K Sell
28,608
-1,247
-4% -$17.8K ﹤0.01% 9740
2024
Q4 		$460K Buy
29,855
+7,084
+31% +$134K ﹤0.01% 8884
2024
Q3 		$525K Buy
22,771
+6,402
+39% +$143K ﹤0.01% 8356
2024
Q2 		$317K Buy
16,369
+15,187
+1,285% +$407K ﹤0.01% 9323
2024
Q1 		$44.4K Sell
1,182
-965
-45% -$39.9K ﹤0.01% 11601
2023
Q4 		$64.9K Buy
2,147
+1,366
+175% +$29.8K ﹤0.01% 11597
2023
Q3 		$17.1K Sell
781
-1,894
-71% -$66.9K ﹤0.01% 11638
2023
Q2 		$104K Sell
2,675
-4,332
-62% -$382K ﹤0.01% 10922
2023
Q1 		$646K Buy
7,007
+5,849
+505% +$734K ﹤0.01% 7941
2022
Q4 		$166K Sell
1,158
-2,842
-71% -$709K ﹤0.01% 10379
2022
Q3 		$910K Buy
4,000
+3,318
+487% +$842K ﹤0.01% 6880
2022
Q2 		$159K Buy
+682
New +$150K ﹤0.01% 10952
2022
Q1 		– Sell
-2,576
Closed -$592K – 12875
2021
Q4 		$721K Buy
+2,576
New +$442K ﹤0.01% 8165
2021
Q3 		– Sell
-1,223
Closed -$201K – 12646
2021
Q2 		$201K Sell
1,223
-4,170
-77% -$849K ﹤0.01% 11587
2021
Q1 		$1.13M Buy
5,393
+3,831
+245% +$879K ﹤0.01% 7409
2020
Q4 		$351K Buy
+1,562
New +$320K ﹤0.01% 8955
2020
Q3 		– Sell
-149
Closed -$36K – 10468
2020
Q2 		$36K Sell
149
-340
-70% -$66.8K ﹤0.01% 9827
2020
Q1 		$56K Buy
489
+113
+30% +$16.8K ﹤0.01% 9621
2019
Q4 		$63K Buy
+376
New +$190K ﹤0.01% 9283

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group's ACET Position: Q4 2025 in Review

Susquehanna International Group sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 2,523 shares — an estimated $32.7K sold.

Susquehanna International Group first reported a position in ACET in Q4 2019 and held it in 20 quarters. The position peaked at $1.13M in Q1 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Susquehanna International Group reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,523 Adicet Bio shares in Q4 2025, an estimated $32.7K.
  • Susquehanna International Group first reported a position in Adicet Bio in Q4 2019 and held it in 20 quarters.
  • Susquehanna International Group's Adicet Bio position peaked at $1.13M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.